The Impacts of Ashwagandha Supplementation on Diurnal Cortisol and Stress Among Women

ConditionStress
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorOklahoma State University Center for Health Sciences

About this trial

The purpose of this project is to better understand the role of ashwagandha on the stress response and wellbeing among healthy, stressed women.

Eligibility criteria

Qualifiers

Female, ages 18-45

No hormonal birth control

Identify as having a regular sleep schedule (eg. sleep by 1am and wake by 9am)

Identify as having a regular menstrual period between 27-32 days apart on average

Disqualifiers

Diagnosed major depressive disorder or generalized anxiety disorder in the last 3 months, any liver, kidney, or thyroid disorder/dysfunction/injury, or diabetes

Using any medication related to cortisol or HPA function such as corticosteroids, antidepressants, anti-psychotics, CNS-depressants (benzodiazepines, non-benzodiazepine sedatives, barbiturates, anti-convulsants, anesthetics), thyroid medications, diabetic medications, or immunosuppressants

Taken any form of ashwagandha within the last 3 months

Daily use of alcohol, nicotine, or other substances

Trial design

Treatments tested in this trial

  • Placebo
  • KSM-66 Ashwagandha

Treatment groups

30 Participants
are divided into 2 treatment groups

Locations

This trial has no locations